WALTHAM, Mass.--(BUSINESS WIRE)--Nomir Medical Technologies, a leader in the development of optical energy technologies for anti-infective medical applications, announced today that the Company will present an abstract detailing positive in vitro and in vivo human data from its study of onychomycosis (toe nail fungus) using Noveon®, a novel dual wavelength optical energy device. Noveon is designed to effect near-infrared photo-inactivation of fungi and bacteria at energies and temperatures that are safe to normal and healthy tissue.
